Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

1.6K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.5K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.5K
Amyloid Fibrils03:03

Amyloid Fibrils

10.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
The Two-State Receptor Model01:29

The Two-State Receptor Model

2.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.5K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

605
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
605
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

452
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
452

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Atomic resolution cryo-EM at 200 keV.

IUCrJ·2026
Same author

De novo design of miniproteins targeting GPCRs.

Nature·2026
Same author

Altered Intracellular Trafficking as a Mechanism for Prolonged Duration of G Protein-Coupled Receptor Activation.

Journal of the American Chemical Society·2026
Same author

Publisher Correction: Elucidating the relationship between affinity and potency in the performance of therapeutic IgE.

Scientific reports·2026
Same author

Conformational Dynamics of Amylin Receptors Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry.

Journal of the American Chemical Society·2026
Same author

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture.

Journal of visualized experiments : JoVE·2026

Video Experimental Relacionado

Updated: Sep 29, 2025

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.6K

Una base estructural para el fenotipo del receptor de amilina

Jianjun Cao1,2, Matthew J Belousoff1,2, Yi-Lynn Liang1

  • 1Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia.

Science (New York, N.Y.)
|March 24, 2022
PubMed
Resumen

Los receptores de amilina (AMYR) y los receptores de calcitonina (CTR) se unen a los péptidos de manera diferente. La comprensión de estos distintos mecanismos de unión es crucial para el desarrollo de nuevos tratamientos contra la obesidad dirigidos a los AMYR.

Más Videos Relacionados

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.1K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

9.6K

Videos de Experimentos Relacionados

Last Updated: Sep 29, 2025

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
09:30

Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps

Published on: July 19, 2024

1.6K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.1K
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

9.6K

Área de la Ciencia:

  • La bioquímica
  • Biología estructural
  • Farmacología

Sus antecedentes:

  • Los receptores de amilina (AMYR) son heterodímeros de los receptores de calcitonina (CTR) y las proteínas que modifican la actividad del receptor (RAMP).
  • Las AMYR y las CTR son objetivos para los tratamientos de la obesidad, pero la base molecular de su unión al péptido y su selectividad sigue sin estar clara.
  • Comprender estas interacciones es vital para el diseño racional de fármacos.

Objetivo del estudio:

  • Determinar la estructura y la dinámica de las AMYR activas unidas a la amilina y a los péptidos basados en CT.
  • Aclarar los mecanismos moleculares subyacentes a la unión y la selectividad de los péptidos en las AMYR y las CTR.
  • Informar sobre el desarrollo de nuevas terapias dirigidas a los AMYR.

Principales métodos:

  • Se determinaron las estructuras de microscopía criolectrónica de los AMYR activos complejos con amilina.
  • Estructuras determinadas de AMY1R y AMY2R con CT de salmón (sCT) y CT humano (hCT).
  • Estructuras determinadas de CTR complejado con amilina, sCT y hCT.

Principales resultados:

  • Los complejos AMYR unidos a la amilina adoptaron una conformación conservada, con un motivo de derivación restringido por RAMP.
  • Los complejos AMYR ligados a CT mostraron estructuras distintas en comparación con los complejos ligados a la amilina.
  • Las estructuras AMYR ligadas a CT se superponen con las estructuras CTR ligadas a CT, lo que indica elementos de unión compartidos.

Conclusiones:

  • La activación de las AMYR por péptidos basados en CT difiere mecánicamente de la activación por amilina.
  • Las diferencias estructurales identificadas proporcionan información sobre la selectividad de AMYR y CTR.
  • Estos hallazgos tienen implicaciones significativas para el desarrollo terapéutico de agonistas de AMYR para la obesidad y otros trastornos metabólicos.